Cargando…

T Regulatory Cells Are Markers of Disease Activity in Multiple Sclerosis Patients

FoxP3(+) Treg cells are believed to play a role in the occurrence of autoimmunity and in the determination of clinical recurrences. Contradictory reports are, however, available describing frequency and function of Treg cells during autoimmune diseases. We examined, by both polychromatic flow cytome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dalla Libera, Dacia, Di Mitri, Diletta, Bergami, Alessandra, Centonze, Diego, Gasperini, Claudio, Grasso, Maria Grazia, Galgani, Simona, Martinelli, Vittorio, Comi, Giancarlo, Avolio, Carlo, Martino, Gianvito, Borsellino, Giovanna, Sallusto, Federica, Battistini, Luca, Furlan, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3123332/ https://www.ncbi.nlm.nih.gov/pubmed/21731726 http://dx.doi.org/10.1371/journal.pone.0021386

Ejemplares similares

FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients
por: Cencioni, M T, et al.
Publicado: (2015)

FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients
por: Cencioni, M T, et al.
Publicado: (2015)

Effect of extracellular vesicles derived from distinct brain cells on Aβ toxicity and assembly: focus on Microglia derived vesicles
por: Joshi, Pooja, et al.
Publicado: (2015)

Immune Regulatory Neural Stem/Precursor Cells Protect from Central Nervous System Autoimmunity by Restraining Dendritic Cell Function
por: Pluchino, Stefano, et al.
Publicado: (2009)

In Vivo Fate Analysis Reveals the Multipotent and Self-Renewal Features of Embryonic AspM Expressing Cells
por: Marinaro, Cinzia, et al.
Publicado: (2011)

Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis
por: Passerini, Gabriella, et al.
Publicado: (2016)

Prognostic value of serum neurofilaments in patients with clinically isolated syndromes
por: Dalla Costa, Gloria, et al.
Publicado: (2019)

Author Correction: Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis
por: Srinivasan, Sundararajan, et al.
Publicado: (2018)

Transcriptional dysregulation of Interferome in experimental and human Multiple Sclerosis
por: Srinivasan, Sundararajan, et al.
Publicado: (2017)

Advances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple Sclerosis
por: Volpe, Elisabetta, et al.
Publicado: (2015)

Dysregulation of MS risk genes and pathways at distinct stages of disease
por: Srinivasan, Sundararajan, et al.
Publicado: (2017)

Salutogenesis and Ayurveda: indications for public health management
por: Morandi, Antonio, et al.
Publicado: (2011)

Fas–Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis
por: Volpe, Elisabetta, et al.
Publicado: (2016)

Increased CD8+ T Cell Response to Epstein-Barr Virus Lytic Antigens in the Active Phase of Multiple Sclerosis
por: Angelini, Daniela F., et al.
Publicado: (2013)

Interleukin 4 modulates microglia homeostasis and attenuates the early slowly progressive phase of amyotrophic lateral sclerosis
por: Rossi, Chiara, et al.
Publicado: (2018)

One, No One, and One Hundred Thousand: T Regulatory Cells' Multiple Identities in Neuroimmunity
por: Sambucci, Manolo, et al.
Publicado: (2019)

The Communication of Multiple Sclerosis Diagnosis: The Patients' Perspective
por: Messina, Maria Josè, et al.
Publicado: (2015)

Interleukin-1β causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53
por: Rossi, Silvia, et al.
Publicado: (2014)

Leukocyte Counts and Ratios Are Predictive of Stroke Outcome and Hemorrhagic Complications Independently of Infections
por: Semerano, Aurora, et al.
Publicado: (2020)

Myeloid cells as target of fingolimod action in multiple sclerosis
por: Di Dario, Marco, et al.
Publicado: (2015)

NK Cells in Cancer: Mechanisms of Dysfunction and Therapeutic Potential
por: Portale, Federica, et al.
Publicado: (2023)

FoxP3 isoforms and PD-1 expression by T regulatory cells in multiple sclerosis
por: Sambucci, Manolo, et al.
Publicado: (2018)

EBV-specific CD8 T lymphocytes and B cells during glatiramer acetate therapy in patients with MS
por: Guerrera, Gisella, et al.
Publicado: (2020)

Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis
por: Gentile, Antonietta, et al.
Publicado: (2016)

Siponimod (BAF312) Activates Nrf2 While Hampering NFκB in Human Astrocytes, and Protects From Astrocyte-Induced Neurodegeneration
por: Colombo, Emanuela, et al.
Publicado: (2020)

Anandamide Suppresses Proliferation and Cytokine Release from Primary Human T-Lymphocytes Mainly via CB(2) Receptors
por: Cencioni, Maria Teresa, et al.
Publicado: (2010)

Letter to the Editor Regarding: A Comprehensive Review on Copemyl(®)
por: Comi, Giancarlo, et al.
Publicado: (2018)

Loss of Circulating CD8+ CD161(high) T Cells in Primary Progressive Multiple Sclerosis
por: Acquaviva, Massimo, et al.
Publicado: (2019)

Selective killing of spinal cord neural stem cells impairs locomotor recovery in a mouse model of spinal cord injury
por: Cusimano, Melania, et al.
Publicado: (2018)

BDNF and Pro-BDNF in Amyotrophic Lateral Sclerosis: A New Perspective for Biomarkers of Neurodegeneration
por: Riolo, Giulia, et al.
Publicado: (2022)

Inferring Multiple Sclerosis Stages from the Blood Transcriptome via Machine Learning
por: Acquaviva, Massimo, et al.
Publicado: (2020)

Laquinimod Modulates Human Astrocyte Function and Dampens Astrocyte-Induced Neurotoxicity during Inflammation
por: Colombo, Emanuela, et al.
Publicado: (2020)

Distinct Expression of Inflammatory Features in T Helper 17 Cells from Multiple Sclerosis Patients
por: Capone, Alessia, et al.
Publicado: (2019)

Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis
por: Rossi, Silvia, et al.
Publicado: (2014)

Editorial: Profiling the tumour microenvironment to unveil biomarkers and develop novel therapeutics for cancer therapy
por: Jaillon, Sebastien, et al.
Publicado: (2023)

Increased Plasmatic Levels of PSA-Expressing Exosomes Distinguish Prostate Cancer Patients from Benign Prostatic Hyperplasia: A Prospective Study
por: Logozzi, Mariantonia, et al.
Publicado: (2019)

MxA mRNA Quantification and Disability Progression in Interferon Beta-Treated Multiple Sclerosis Patients
por: Serana, Federico, et al.
Publicado: (2014)

Changes in cortical motor outputs after a motor relapse of multiple sclerosis
por: Chieffo, Raffaella, et al.
Publicado: (2019)

Treatment Challenges of a Primary Vertebral Artery Aneurysm Causing Recurrent Ischemic Strokes
por: Strambo, Davide, et al.
Publicado: (2017)

New treatments for the mucopolysaccharidoses: from pathophysiology to therapy
por: Fecarotta, Simona, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_udr31a5iq41s251a9r72ifpski